Very Late Antigen 1 Blockade Markedly Promotes Survival of Corneal Allografts

Overview

Journal Arch Ophthalmol

Publisher American Medical Association

Specialty Ophthalmology

Date 2007 Jun 15

PMID 17562989

Citations 24

Authors

Lu Chen

Syed Huq

Humphrey Gardner

Antonin R de Fougerolles

Stefano Barabino

M Reza Dana

Affiliations

Soon will be listed here.

Abstract

Objective: To investigate the role of very late antigen 1 (VLA-1) (also known as integrin receptor alpha(1)beta(1)) in corneal transplantation inflammation and allograft survival.

Methods: Cell infiltration and vasculogenesis (both angiogenesis and lymphangiogenesis) associated with allodisparate corneal transplantation were assessed in VLA-1-deficient conditions and controls by immunofluorescent microscopic studies. Corneal allograft survival was also assessed after anti-VLA-1 antibody treatment and in VLA-1 knockout recipient mice.

Results: Anti-VLA-1 antibody treatment leads to a profound reduction in the granulocytic, monocytic, and T-cell infiltration after corneal transplantation. In addition, corneal angiogenesis and lymphangiogenesis were both significantly suppressed in VLA-1 knockout mice. Remarkably, universal graft survival was observed in both anti-VLA-1 antibody treatment and knockout mice.

Conclusions: Very late antigen 1 blockade markedly reduces inflammation and inflammation-induced tissue responses, including vasculogenic responses, associated with corneal transplantation and promotes allograft survival.

Clinical Relevance: These studies offer insights into important integrin-mediated mechanisms of corneal transplant-related inflammation and provide possible new integrin-based immunotherapies for transplant rejection.

Citing Articles

Biomechanical control of lymphatic vessel physiology and functions.

Angeli V, Lim H Cell Mol Immunol. 2023; 20(9):1051-1062.

PMID: 37264249 PMC: 10469203. DOI: 10.1038/s41423-023-01042-9.

Variable Responses to Corneal Grafts: Insights from Immunology and Systems Biology.

Di Zazzo A, Lee S, Sung J, Niutta M, Coassin M, Mashaghi A J Clin Med. 2020; 9(2).

PMID: 32098130 PMC: 7074162. DOI: 10.3390/jcm9020586.

ALCAM Mediates DC Migration Through Afferent Lymphatics and Promotes Allospecific Immune Reactions.

Willrodt A, Salabarria A, Schineis P, Ignatova D, Hunter M, Vranova M Front Immunol. 2019; 10:759.

PMID: 31031759 PMC: 6473055. DOI: 10.3389/fimmu.2019.00759.

Effector and Regulatory T Cell Trafficking in Corneal Allograft Rejection.

Amouzegar A, Chauhan S Mediators Inflamm. 2017; 2017:8670280.

PMID: 28539707 PMC: 5429952. DOI: 10.1155/2017/8670280.

Angiopoietin-2 Blockade Promotes Survival of Corneal Transplants.

Zhang L, Li G, Sessa R, Kang G, Shi M, Ge S Invest Ophthalmol Vis Sci. 2017; 58(1):79-86.

PMID: 28061513 PMC: 5231909. DOI: 10.1167/iovs.16-20485.

References

Hemler M . VLA proteins in the integrin family: structures, functions, and their role on leukocytes. Annu Rev Immunol. 1990; 8:365-400. DOI: 10.1146/annurev.iy.08.040190.002053. View

Ben-Horin S, Bank I . The role of very late antigen-1 in immune-mediated inflammation. Clin Immunol. 2004; 113(2):119-29. DOI: 10.1016/j.clim.2004.06.007. View

Dana M, Yamada J, Streilein J . Topical interleukin 1 receptor antagonist promotes corneal transplant survival. Transplantation. 1997; 63(10):1501-7. DOI: 10.1097/00007890-199705270-00022. View

Dana M, Zhu S, Yamada J . Topical modulation of interleukin-1 activity in corneal neovascularization. Cornea. 1998; 17(4):403-9. DOI: 10.1097/00003226-199807000-00011. View

Dumont D, Jussila L, Taipale J, Lymboussaki A, Mustonen T, Pajusola K . Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. Science. 1998; 282(5390):946-9. DOI: 10.1126/science.282.5390.946. View

Wigle J, Oliver G . Prox1 function is required for the development of the murine lymphatic system. Cell. 1999; 98(6):769-78. DOI: 10.1016/s0092-8674(00)81511-1. View

Vlahakis N, Young B, Atakilit A, Sheppard D . The lymphangiogenic vascular endothelial growth factors VEGF-C and -D are ligands for the integrin alpha9beta1. J Biol Chem. 2004; 280(6):4544-52. PMC: 1368959. DOI: 10.1074/jbc.M412816200. View

Brown P . Lymphatic system: unlocking the drains. Nature. 2005; 436(7050):456-8. DOI: 10.1038/436456a. View

Alitalo K, Tammela T, Petrova T . Lymphangiogenesis in development and human disease. Nature. 2005; 438(7070):946-53. DOI: 10.1038/nature04480. View

10.

Yamada J, Streilein J, Dana M . Role of tumor necrosis factor receptors TNFR-I (P55) and TNFR-II (P75) in corneal transplantation. Transplantation. 1999; 68(7):944-9. DOI: 10.1097/00007890-199910150-00008. View

11.

Pozzi A, Moberg P, Miles L, Wagner S, Soloway P, Gardner H . Elevated matrix metalloprotease and angiostatin levels in integrin alpha 1 knockout mice cause reduced tumor vascularization. Proc Natl Acad Sci U S A. 2000; 97(5):2202-7. PMC: 15778. DOI: 10.1073/pnas.040378497. View

12.

de Fougerolles A, Sprague A, Nickerson-Nutter C, Rennert P, Gardner H, Gotwals P . Regulation of inflammation by collagen-binding integrins alpha1beta1 and alpha2beta1 in models of hypersensitivity and arthritis. J Clin Invest. 2000; 105(6):721-9. PMC: 377459. DOI: 10.1172/JCI7911. View

13.

Zhu S, Yamada J, Streilein J, Dana M . ICAM-1 deficiency suppresses host allosensitization and rejection of MHC-disparate corneal transplants. Transplantation. 2001; 69(5):1008-13. DOI: 10.1097/00007890-200003150-00061. View

14.

Dana M, Qian Y, Hamrah P . Twenty-five-year panorama of corneal immunology: emerging concepts in the immunopathogenesis of microbial keratitis, peripheral ulcerative keratitis, and corneal transplant rejection. Cornea. 2000; 19(5):625-43. DOI: 10.1097/00003226-200009000-00008. View

15.

Qian Y, Boisgerault F, Benichou G, Dana M . Blockade of CD40-CD154 costimulatory pathway promotes survival of allogeneic corneal transplants. Invest Ophthalmol Vis Sci. 2001; 42(5):987-94. View

16.

Yamagami S, Dana M . The critical role of lymph nodes in corneal alloimmunization and graft rejection. Invest Ophthalmol Vis Sci. 2001; 42(6):1293-8. View

17.

Jackson D, Prevo R, Clasper S, Banerji S . LYVE-1, the lymphatic system and tumor lymphangiogenesis. Trends Immunol. 2001; 22(6):317-21. DOI: 10.1016/s1471-4906(01)01936-6. View

18.

Senger D, Perruzzi C, Streit M, Koteliansky V, de Fougerolles A, Detmar M . The alpha(1)beta(1) and alpha(2)beta(1) integrins provide critical support for vascular endothelial growth factor signaling, endothelial cell migration, and tumor angiogenesis. Am J Pathol. 2002; 160(1):195-204. PMC: 1867136. DOI: 10.1016/s0002-9440(10)64363-5. View

19.

Cursiefen C, Chen L, Dana M, Wayne Streilein J . Corneal lymphangiogenesis: evidence, mechanisms, and implications for corneal transplant immunology. Cornea. 2003; 22(3):273-81. DOI: 10.1097/00003226-200304000-00021. View

20.

Perruzzi C, de Fougerolles A, Koteliansky V, Whelan M, Westlin W, Senger D . Functional overlap and cooperativity among alphav and beta1 integrin subfamilies during skin angiogenesis. J Invest Dermatol. 2003; 120(6):1100-9. DOI: 10.1046/j.1523-1747.2003.12236.x. View